SBI Healthcare Opportunities Fund holds 36 instruments (98.31% equity), led by Sun Pharmaceutical Industries Limited (12.72%), Divi's Laboratories Limited (7.46%) and Acutaas Chemicals Limited (5.17%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of SBI Healthcare Opportunities Fund, managed by SBI Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 36 instruments with an equity allocation of 98.31%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
SBI Healthcare Opportunities Fund's top 10 holdings account for 56.27% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 93.81% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 3 new positions and exited 2 positions, with Cipla Limited seeing the largest move (+1.55pp to 5.07%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Cipla Limited | 3.52% → 5.07% | ▲ +1.55 |
| Divi's Laboratories Limited | 5.92% → 7.46% | ▲ +1.54 |
| Sun Pharmaceutical Industries Limited | 11.18% → 12.72% | ▲ +1.54 |
| Torrent Pharmaceuticals Limited | 3.33% → 4.74% | ▲ +1.41 |
| Laurus Labs Limited | 3.64% → 4.04% | ▲ +0.4 |
| Global Health Limited | 1.47% → 1.67% | ▲ +0.2 |
| Nephrocare Health Services Limited | 1.08% → 1.2% | ▲ +0.12 |
| Stock | Weight | Change |
|---|---|---|
| Acutaas Chemicals Limited | 6.35% → 5.17% | ▼ -1.18 |
| Mankind Pharma Limited | 2.85% → 1.83% | ▼ -1.02 |
| Max Healthcare Institute Limited | 5.08% → 4.58% | ▼ -0.5 |
| Aether Industries Limited | 2.72% → 2.28% | ▼ -0.44 |
| Aurobindo Pharma Limited | 4.17% → 3.86% | ▼ -0.31 |
| Cohance Lifesciences Limited | 2.01% → 1.73% | ▼ -0.28 |
| Fortis Healthcare Limited | 2.87% → 2.63% | ▼ -0.24 |
| Apollo Hospitals Enterprise Limited | 5.21% → 4.98% | ▼ -0.23 |
| Gland Pharma Limited | 3% → 2.78% | ▼ -0.22 |
| Krishna Institute of Medical Sciences Limited | 2.17% → 1.98% | ▼ -0.19 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: SBI Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.